<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02430272</url>
  </required_header>
  <id_info>
    <org_study_id>DSC-01-choe</org_study_id>
    <nct_id>NCT02430272</nct_id>
  </id_info>
  <brief_title>Anticholinergic Premedication Induced Fever in Pediatric Ambulatory Anesthesia With Ketamine</brief_title>
  <official_title>Anticholinergic Premedication Induced Fever in Pediatric Ambulatory Anesthesia With Ketamine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Inje University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Inje University</source>
  <brief_summary>
    <textblock>
      Anticholinergic drugs have traditionally been used for their antisialagogue properties. But
      use of anticholinergic drugs can interfere with thermoregulation via inhibition of the
      parasympathetically mediated sweat secretion. Sweating inhibition can reduce heat
      elimination, and children's thermoregulation depend more on sweating than adults and they can
      become hyperthermic when given these agents.

      The investigators evaluated the fever-causing effects of adjunctive anticholinergics in
      children under general anesthesia using ketamine.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Body temperature</measure>
    <time_frame>every 30 minutes from base line ( up to 90min )</time_frame>
    <description>measured body temperature at three times in both ears and the highest value was selected.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oral secretion (VAS)</measure>
    <time_frame>up to operative end</time_frame>
    <description>Oral secretion during the whole procedure was recorded by the researcher</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">84</enrollment>
  <condition>Fever</condition>
  <arm_group>
    <arm_group_label>Anticholinergic premedication</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Premedication with 0.005mg/Kg of glycopyrrolate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Same volume of normal saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Glycopyrrolate</intervention_name>
    <description>Intravenously administered 0.005mg/Kg of glycopyrrolate in intervention group</description>
    <arm_group_label>Anticholinergic premedication</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologists (ASA) Physical Status classification I

          -  underwent surgery between 8 to 9 am

          -  undergoing ambulatory anesthesia with ketamine

        Exclusion Criteria:

          -  who required endotracheal intubation

          -  who were administered with medications other than ketamine
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Months</minimum_age>
    <maximum_age>8 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Won Joo Choe, M.D. Ph.D</last_name>
    <role>Study Chair</role>
    <affiliation>Inje Univ.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ilsan Paik hospital</name>
      <address>
        <city>Goyang-si</city>
        <state>Gyeonggi-do</state>
        <zip>411-706</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 22, 2015</study_first_submitted>
  <study_first_submitted_qc>April 25, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 30, 2015</study_first_posted>
  <last_update_submitted>April 29, 2015</last_update_submitted>
  <last_update_submitted_qc>April 29, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 1, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Inje University</investigator_affiliation>
    <investigator_full_name>Won Joo Choe</investigator_full_name>
    <investigator_title>M.D., Ph.D., Associate professor,</investigator_title>
  </responsible_party>
  <keyword>Child</keyword>
  <keyword>outpatient</keyword>
  <keyword>premedication</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fever</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketamine</mesh_term>
    <mesh_term>Glycopyrrolate</mesh_term>
    <mesh_term>Cholinergic Antagonists</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

